JP7847966B2 - 医薬製剤およびその製造方法 - Google Patents

医薬製剤およびその製造方法

Info

Publication number
JP7847966B2
JP7847966B2 JP2021174126A JP2021174126A JP7847966B2 JP 7847966 B2 JP7847966 B2 JP 7847966B2 JP 2021174126 A JP2021174126 A JP 2021174126A JP 2021174126 A JP2021174126 A JP 2021174126A JP 7847966 B2 JP7847966 B2 JP 7847966B2
Authority
JP
Japan
Prior art keywords
mass
pharmaceutical formulation
volatile solvent
core particle
particularly limited
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021174126A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022069437A (ja
JP2022069437A5 (https=
Inventor
俊行 稲田
良成 金山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Pharma Co Ltd
Original Assignee
Fuji Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Pharma Co Ltd filed Critical Fuji Pharma Co Ltd
Publication of JP2022069437A publication Critical patent/JP2022069437A/ja
Publication of JP2022069437A5 publication Critical patent/JP2022069437A5/ja
Application granted granted Critical
Publication of JP7847966B2 publication Critical patent/JP7847966B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2021174126A 2020-10-23 2021-10-25 医薬製剤およびその製造方法 Active JP7847966B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020178400 2020-10-23
JP2020178400 2020-10-23

Publications (3)

Publication Number Publication Date
JP2022069437A JP2022069437A (ja) 2022-05-11
JP2022069437A5 JP2022069437A5 (https=) 2024-10-29
JP7847966B2 true JP7847966B2 (ja) 2026-04-20

Family

ID=81521745

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021174126A Active JP7847966B2 (ja) 2020-10-23 2021-10-25 医薬製剤およびその製造方法

Country Status (1)

Country Link
JP (1) JP7847966B2 (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006160730A (ja) 2004-11-12 2006-06-22 Taisho Pharmaceut Co Ltd 低融点薬物含有粉粒体及びその製造方法
JP2007528389A (ja) 2004-03-10 2007-10-11 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 安定化した過飽和固体親油性薬物
JP2010065023A (ja) 2008-08-14 2010-03-25 Lion Corp 脂溶性ビタミンおよび／または脂溶性色素含有粉体
WO2016194805A1 (ja) 2015-05-30 2016-12-08 富田製薬株式会社 油状物質含有粉末組成物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007528389A (ja) 2004-03-10 2007-10-11 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 安定化した過飽和固体親油性薬物
JP2006160730A (ja) 2004-11-12 2006-06-22 Taisho Pharmaceut Co Ltd 低融点薬物含有粉粒体及びその製造方法
JP2010065023A (ja) 2008-08-14 2010-03-25 Lion Corp 脂溶性ビタミンおよび／または脂溶性色素含有粉体
WO2016194805A1 (ja) 2015-05-30 2016-12-08 富田製薬株式会社 油状物質含有粉末組成物

Also Published As

Publication number Publication date
JP2022069437A (ja) 2022-05-11

Similar Documents

Publication Publication Date Title
JP6560289B2 (ja) 新たな医薬組成物
CA2895529C (en) Supersaturated stabilized nanoparticles for poorly soluble drugs
EP2950923B1 (en) Porous silica gel as a carrier for liquid technologies
AU2021107168A4 (en) Vitamin d pediatric dosage forms, methods of making and using
US20120225118A1 (en) Compositions for delivery of insoluble agents
JP7196239B2 (ja) Ｅｄ－７１の固体分散体および油分分散体を含む医薬組成物
JP2013537903A (ja) カラノライド、その誘導体及び類似体についての医薬組成物並びにそれを製造するための方法
EP1874357A1 (en) Pharmaceutical dosage forms comprising a lipid phase
JP2016210799A (ja) 三種混合製剤
HK1208130A1 (en) Extended-release levetiracetam and method of preparation
JP7640453B2 (ja) 医薬製剤およびその製造方法
JP6374879B2 (ja) 骨粗しょう症治療用の安定な医薬組成物
JP7847966B2 (ja) 医薬製剤およびその製造方法
WO2017093890A1 (en) Clobazam tablet formulation and process for its preparation
JP5774308B2 (ja) 水溶性ビノレルビン塩の安定な医薬組成物
WO2022072099A9 (en) Immediate release dosage forms, methods of making and using
JP2014530828A (ja) 有機化合物におけるまたは有機化合物に関連する改善
KR102262740B1 (ko) 밀크시슬을 함유한 정제 조성물 및 이의 제조 방법
HK40033229A (en) Porous silica gel as a carrier for liquid technologies

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20211112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241021

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241021

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20250522

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260209

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260310

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260408

R150 Certificate of patent or registration of utility model

Ref document number: 7847966

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150